MSK’s submission to the review of the National Medicines Policy
The National Medicines Policy (NMP) sets the direction and approach for the availability and use of medicines in Australia. It is applicable to medicines research, development, regulation, manufacture, evaluation, supply, and access. It promotes the quality use of medicines by focusing on the needs of people and the responsibilities of health professionals to support all communities in Australia to achieve optimal health outcomes.
MSK made a submission in October 2021 as part of the review consultation. Read here.
MSK’s submission to the Federal Treasurer for the Federal Budget 2022-2023
On 6 December 2021, the Minister for Housing and Assistant Treasurer called for submissions from individuals, businesses and community groups on their views regarding priorities for the 2022-23 Federal Budget.
MSK submitted their 2022-2023 pre-budget submission in January 2022. Read here.
MSK’s submission to the Standing Committee on Health, Aged Care and Sport Parliamentary Inquiry into Childhood Rheumatic Disease
Following a referral in late 2021 from the Minister for Health, The Hon Greg Hunt MP, the House of Representatives Standing Committee on Health, Aged Care and Sport is inquiring into, and reporting on, childhood rheumatic diseases and juvenile arthritis (referred to collectively as ‘childhood rheumatic diseases’).
MSK made a submission to the Inquiry in February 2022. Read here.